Lanean...
Multiple Source Biosimilar Insulin, What’s a Provider to Do?
In the United States the FDA designates generic products that are bioequivalent as AB substitutable (FDA rating signifying the approved application contains adequate scientific evidence establishing through in vivo and/or in vitro studies the bioequivalence of the product to a selected reference pro...
Gorde:
| Argitaratua izan da: | J Diabetes Sci Technol |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4454116/ https://ncbi.nlm.nih.gov/pubmed/24876532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296813511748 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|